Genmab A/S (GMAB) Stock Chart & Stock Price History → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free GMAB Stock Alerts $29.91 -0.72 (-2.35%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Genmab A/S Stock Price Performance5 Day Performance-0.03%1 Month Performance+7.71%3 Month Performance-6.06%6 Month Performance-15.20%Year-To-Date Performance-6.06%1 Year Performance-20.39% Receive GMAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> GMAB Stock Chart for Friday, March, 29, 2024 GMAB Chart by TradingView Genmab A/S Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$30.63$29.91-2.35%$30.56$29.84361,389 shs$19.76 billion03/27/2024$30.83$30.63-0.65%$30.63$30.11319,427 shs$20.24 billion03/26/2024$29.98$30.83+2.84%$31.02$30.68538,488 shs$20.37 billion03/25/2024$29.92$29.98+0.20%$30.10$29.89332,598 shs$19.81 billion03/22/2024$29.56$29.92+1.22%$30.27$29.83358,837 shs$19.77 billion03/21/2024$29.44$29.56+0.41%$29.93$29.49369,800 shs$19.53 billion Get the Latest News and Ratings for GMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$29.64$29.44-0.67%$29.57$29.28286,675 shs$19.45 billion03/19/2024$29.69$29.64-0.17%$29.68$29.36326,680 shs$19.58 billion03/18/2024$29.94$29.69-0.84%$30.01$29.68411,189 shs$19.62 billion03/15/2024$30.30$29.94-1.19%$30.22$29.691.01 million shs$19.78 billion03/14/2024$31.34$30.30-3.32%$31.26$30.11631,143 shs$20.02 billion03/13/2024$31.43$31.34-0.29%$31.88$31.27368,541 shs$20.71 billion03/12/2024$31.68$31.43-0.79%$31.48$31.05749,959 shs$20.77 billion03/11/2024$30.30$31.68+4.55%$31.81$30.961.22 million shs$20.93 billion03/08/2024$29.41$30.30+3.03%$30.31$29.84492,492 shs$20.02 billion03/07/2024$28.86$29.41+1.91%$29.52$29.23254,754 shs$19.43 billion03/06/2024$28.75$28.86+0.38%$29.19$28.86479,237 shs$19.07 billion03/05/2024$28.51$28.75+0.84%$28.90$28.50618,549 shs$19.00 billion03/04/2024$29.29$28.51-2.66%$28.81$28.39553,391 shs$18.84 billion03/01/2024$27.77$29.29+5.47%$29.48$28.58551,844 shs$19.35 billion02/29/2024$27.67$27.77+0.36%$28.26$27.76893,184 shs$18.35 billion02/28/2024$29.05$27.67-4.75%$28.34$27.511.75 million shs$18.28 billion02/27/2024$29.40$29.05-1.19%$29.25$28.85435,996 shs$19.19 billion02/26/2024$29.16$29.40+0.82%$29.46$29.14893,501 shs$19.43 billion02/23/2024$29.11$29.16+0.17%$29.31$29.05594,294 shs$19.27 billion02/22/2024$28.95$29.11+0.55%$29.19$28.96450,479 shs$19.23 billion02/21/2024$28.95$28.95$28.97$28.64500,300 shs$19.13 billion02/20/2024$28.71$28.95+0.84%$28.97$28.69563,731 shs$19.13 billion02/19/2024$28.71$28.71$29.00$28.43633,100 shs$18.97 billion02/16/2024$28.23$28.71+1.70%$29.00$28.43633,159 shs$18.97 billion02/15/2024$27.59$28.23+2.32%$29.15$27.981.32 million shs$18.65 billion02/14/2024$26.43$27.59+4.39%$28.21$26.701.17 million shs$18.23 billion02/13/2024$27.49$26.43-3.86%$26.85$26.32585,236 shs$17.46 billion02/12/2024$27.84$27.49-1.26%$28.01$27.38754,399 shs$18.16 billion02/09/2024$27.79$27.84+0.18%$27.88$27.60483,682 shs$18.40 billion02/08/2024$27.97$27.79-0.64%$27.81$27.50426,242 shs$18.36 billion02/07/2024$28.15$27.97-0.64%$27.99$27.73505,266 shs$18.48 billion02/06/2024$27.57$28.15+2.10%$28.23$27.80709,056 shs$18.60 billion02/05/2024$27.80$27.57-0.83%$27.74$27.34800,360 shs$18.22 billion02/02/2024$28.17$27.80-1.31%$28.03$27.54959,911 shs$18.37 billion[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>02/01/2024$27.61$28.17+2.03%$28.25$27.68562,920 shs$18.61 billion01/31/2024$28.13$27.61-1.85%$28.30$27.58472,177 shs$18.24 billion01/30/2024$28.29$28.13-0.57%$28.42$28.06406,515 shs$18.59 billion01/29/2024$27.92$28.29+1.33%$28.34$27.73579,816 shs$18.69 billion01/26/2024$28.15$27.92-0.82%$28.13$27.86593,195 shs$18.45 billion01/25/2024$27.63$28.15+1.88%$28.20$27.80658,592 shs$18.60 billion01/24/2024$27.96$27.63-1.18%$27.98$27.42829,647 shs$18.26 billion01/23/2024$28.68$27.96-2.51%$28.04$27.311.10 million shs$18.47 billion01/22/2024$28.94$28.68-0.90%$28.90$28.34739,142 shs$18.95 billion01/19/2024$28.72$28.94+0.77%$29.01$28.52704,879 shs$19.12 billion01/18/2024$29.15$28.72-1.48%$28.78$28.261.09 million shs$18.97 billion01/17/2024$29.98$29.15-2.77%$29.23$28.80940,181 shs$19.26 billion01/16/2024$31.61$29.98-5.16%$30.00$29.481.13 million shs$19.81 billion01/15/2024$31.61$31.61$31.97$31.58958,700 shs$20.88 billion01/12/2024$31.89$31.61-0.88%$31.97$31.58934,932 shs$20.88 billion01/11/2024$32.29$31.89-1.24%$31.89$31.20705,251 shs$21.07 billion01/10/2024$32.39$32.29-0.31%$32.56$32.13220,304 shs$21.33 billion01/09/2024$32.77$32.39-1.16%$32.56$32.26299,297 shs$21.40 billion01/08/2024$31.61$32.77+3.67%$32.88$31.90589,603 shs$21.65 billion01/05/2024$31.75$31.61-0.44%$31.92$31.37333,919 shs$20.88 billion01/04/2024$31.16$31.75+1.89%$31.86$31.55303,798 shs$20.98 billion01/03/2024$32.11$31.16-2.96%$31.60$31.02374,894 shs$20.59 billion01/02/2024$31.84$32.11+0.85%$32.48$31.33563,181 shs$21.21 billion01/01/2024$31.84$31.84$32.02$31.77241,400 shs$21.04 billion12/29/2023$31.95$31.84-0.34%$32.01$31.77241,408 shs$21.04 billion12/28/2023$31.76$31.95+0.60%$32.19$31.79220,409 shs$21.11 billion Related Companies: Alnylam Pharmaceuticals Stock Chart BioMarin Pharmaceutical Stock Chart BeiGene Stock Chart Teva Pharmaceutical Industries Stock Chart Viatris Stock Chart Karuna Therapeutics Stock Chart Dr. Reddy's Laboratories Stock Chart Sarepta Therapeutics Stock Chart United Therapeutics Stock Chart Legend Biotech Stock Chart Receive GMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMAB) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.